COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES

COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES

This invention relates to NPC-1 antigen on the MUC5AC protein and 16C3 antigen on CEACAM5 and CEACAM6 proteins, and 31.1 epitope on the A33 protein are differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer, and diagnostic and the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SEMENUK, Mark, STAFFORD, Lewis Joe, KANTOR, Judith, BRISTOL, Andrew J, WANG, Xue-Ping, DU, Xiulian, LUKA, Janos
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SEMENUK, Mark
STAFFORD, Lewis Joe
KANTOR, Judith
BRISTOL, Andrew J
WANG, Xue-Ping
DU, Xiulian
LUKA, Janos
description This invention relates to NPC-1 antigen on the MUC5AC protein and 16C3 antigen on CEACAM5 and CEACAM6 proteins, and 31.1 epitope on the A33 protein are differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer, and diagnostic and therapeutic usages. Further, NPC-1, 16C3, and/or 31.1 epitope specific antibodies and diagnostic and therapeutic methods of use.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3327035A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3327035A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3327035A13</originalsourceid><addsrcrecordid>eNrjZLBy9vfx91Nw9HNRCHD0cw5ydQxWcAYyXIMUggNcnT3dPJ2BkiGe7q5-wWBVII6Tv4unazAPA2taYk5xKi-U5mZQcHMNcfbQTS3Ij08tLkhMTs1LLYl3DTA2NjI3MDZ1NDQmQgkANGAoMg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES</title><source>esp@cenet</source><creator>SEMENUK, Mark ; STAFFORD, Lewis Joe ; KANTOR, Judith ; BRISTOL, Andrew J ; WANG, Xue-Ping ; DU, Xiulian ; LUKA, Janos</creator><creatorcontrib>SEMENUK, Mark ; STAFFORD, Lewis Joe ; KANTOR, Judith ; BRISTOL, Andrew J ; WANG, Xue-Ping ; DU, Xiulian ; LUKA, Janos</creatorcontrib><description>This invention relates to NPC-1 antigen on the MUC5AC protein and 16C3 antigen on CEACAM5 and CEACAM6 proteins, and 31.1 epitope on the A33 protein are differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer, and diagnostic and therapeutic usages. Further, NPC-1, 16C3, and/or 31.1 epitope specific antibodies and diagnostic and therapeutic methods of use.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180530&amp;DB=EPODOC&amp;CC=EP&amp;NR=3327035A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180530&amp;DB=EPODOC&amp;CC=EP&amp;NR=3327035A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SEMENUK, Mark</creatorcontrib><creatorcontrib>STAFFORD, Lewis Joe</creatorcontrib><creatorcontrib>KANTOR, Judith</creatorcontrib><creatorcontrib>BRISTOL, Andrew J</creatorcontrib><creatorcontrib>WANG, Xue-Ping</creatorcontrib><creatorcontrib>DU, Xiulian</creatorcontrib><creatorcontrib>LUKA, Janos</creatorcontrib><title>COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES</title><description>This invention relates to NPC-1 antigen on the MUC5AC protein and 16C3 antigen on CEACAM5 and CEACAM6 proteins, and 31.1 epitope on the A33 protein are differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer, and diagnostic and therapeutic usages. Further, NPC-1, 16C3, and/or 31.1 epitope specific antibodies and diagnostic and therapeutic methods of use.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBy9vfx91Nw9HNRCHD0cw5ydQxWcAYyXIMUggNcnT3dPJ2BkiGe7q5-wWBVII6Tv4unazAPA2taYk5xKi-U5mZQcHMNcfbQTS3Ij08tLkhMTs1LLYl3DTA2NjI3MDZ1NDQmQgkANGAoMg</recordid><startdate>20180530</startdate><enddate>20180530</enddate><creator>SEMENUK, Mark</creator><creator>STAFFORD, Lewis Joe</creator><creator>KANTOR, Judith</creator><creator>BRISTOL, Andrew J</creator><creator>WANG, Xue-Ping</creator><creator>DU, Xiulian</creator><creator>LUKA, Janos</creator><scope>EVB</scope></search><sort><creationdate>20180530</creationdate><title>COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES</title><author>SEMENUK, Mark ; STAFFORD, Lewis Joe ; KANTOR, Judith ; BRISTOL, Andrew J ; WANG, Xue-Ping ; DU, Xiulian ; LUKA, Janos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3327035A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>SEMENUK, Mark</creatorcontrib><creatorcontrib>STAFFORD, Lewis Joe</creatorcontrib><creatorcontrib>KANTOR, Judith</creatorcontrib><creatorcontrib>BRISTOL, Andrew J</creatorcontrib><creatorcontrib>WANG, Xue-Ping</creatorcontrib><creatorcontrib>DU, Xiulian</creatorcontrib><creatorcontrib>LUKA, Janos</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SEMENUK, Mark</au><au>STAFFORD, Lewis Joe</au><au>KANTOR, Judith</au><au>BRISTOL, Andrew J</au><au>WANG, Xue-Ping</au><au>DU, Xiulian</au><au>LUKA, Janos</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES</title><date>2018-05-30</date><risdate>2018</risdate><abstract>This invention relates to NPC-1 antigen on the MUC5AC protein and 16C3 antigen on CEACAM5 and CEACAM6 proteins, and 31.1 epitope on the A33 protein are differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer, and diagnostic and therapeutic usages. Further, NPC-1, 16C3, and/or 31.1 epitope specific antibodies and diagnostic and therapeutic methods of use.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3327035A1
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T14%3A34%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SEMENUK,%20Mark&rft.date=2018-05-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3327035A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true